Profile | GDS5420 / 209894_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 905.39 | 77 |
GSM1296119 | B_lesional_pre-dose | 2616.84 | 92 |
GSM1296076 | C_lesional_pre-dose | 1690.43 | 86 |
GSM1296092 | D_lesional_pre-dose | 968.72 | 78 |
GSM1296103 | E_lesional_pre-dose | 1360.09 | 84 |
GSM1296078 | F_lesional_pre-dose | 2367.79 | 90 |
GSM1296107 | G_lesional_pre-dose | 2372.29 | 91 |
GSM1296109 | H_lesional_pre-dose | 1214.46 | 82 |
GSM1296080 | I_lesional_pre-dose | 1391.44 | 84 |
GSM1296090 | J_lesional_pre-dose | 1358.45 | 83 |
GSM1296074 | K_lesional_pre-dose | 772.26 | 75 |
GSM1296111 | L_lesional_pre-dose | 1252.38 | 83 |
GSM1296099 | M_lesional_pre-dose | 1604.23 | 86 |
GSM1296086 | O_lesional_pre-dose | 825.38 | 76 |
GSM1296117 | P_lesional_pre-dose | 1608.83 | 87 |
GSM1296113 | Q_lesional_pre-dose | 2938.81 | 94 |
GSM1296096 | R_lesional_pre-dose | 1223.56 | 82 |
GSM1296105 | S_lesional_pre-dose | 2621.81 | 93 |
GSM1296098 | T_lesional_pre-dose | 614.82 | 71 |
GSM1296101 | U_lesional_pre-dose | 1542.44 | 86 |
GSM1296121 | V_lesional_pre-dose | 1563.15 | 86 |
GSM1296088 | W_lesional_pre-dose | 1361.34 | 84 |
GSM1296082 | X_lesional_pre-dose | 1265.64 | 82 |
GSM1296115 | Y_lesional_pre-dose | 2073.77 | 90 |
GSM1296084 | Z_lesional_pre-dose | 1090.35 | 80 |
GSM1296072 | B_lesional_day8 | 2550.86 | 92 |
GSM1296069 | L_lesional_day8 | 903.78 | 78 |
GSM1296071 | P_lesional_day8 | 3281.98 | 96 |
GSM1296070 | Y_lesional_day8 | 3250.28 | 95 |
GSM1296073 | V_lesional_day8 | 1538.18 | 85 |
GSM1296034 | A_lesional_day15 | 2265.87 | 92 |
GSM1296041 | G_lesional_day15 | 1282.85 | 83 |
GSM1296035 | R_lesional_day15 | 1289.68 | 83 |
GSM1296038 | U_lesional_day15 | 1430.95 | 84 |
GSM1296047 | B_lesional_day15 | 1961.62 | 89 |
GSM1296039 | E_lesional_day15 | 1359.65 | 84 |
GSM1296042 | H_lesional_day15 | 2025.76 | 90 |
GSM1296043 | L_lesional_day15 | 1231.01 | 83 |
GSM1296037 | M_lesional_day15 | 2946.65 | 93 |
GSM1296046 | P_lesional_day15 | 2809.2 | 94 |
GSM1296044 | Q_lesional_day15 | 4084.12 | 97 |
GSM1296045 | Y_lesional_day15 | 3333 | 95 |
GSM1296025 | C_lesional_day15 | 1982.12 | 89 |
GSM1296033 | D_lesional_day15 | 1292.03 | 83 |
GSM1296027 | I_lesional_day15 | 3681.38 | 95 |
GSM1296032 | J_lesional_day15 | 2028.43 | 90 |
GSM1296024 | K_lesional_day15 | 2051.2 | 89 |
GSM1296031 | W_lesional_day15 | 2029.84 | 90 |
GSM1296028 | X_lesional_day15 | 2139.5 | 90 |
GSM1296029 | Z_lesional_day15 | 1631.25 | 86 |
GSM1296026 | F_lesional_day15 | 1371 | 84 |
GSM1296030 | O_lesional_day15 | 963.51 | 78 |
GSM1296040 | S_lesional_day15 | 1778.45 | 88 |
GSM1296036 | T_lesional_day15 | 937.01 | 78 |
GSM1296048 | V_lesional_day15 | 1961.13 | 89 |
GSM1296059 | A_lesional_day43 | 1967.04 | 89 |
GSM1296066 | G_lesional_day43 | 2364.35 | 91 |
GSM1296060 | R_lesional_day43 | 1565.95 | 86 |
GSM1296063 | U_lesional_day43 | 2290.85 | 90 |
GSM1296064 | E_lesional_day43 | 1393.16 | 84 |
GSM1296067 | H_lesional_day43 | 2598.82 | 93 |
GSM1296062 | M_lesional_day43 | 1339.07 | 84 |
GSM1296068 | Q_lesional_day43 | 3557.54 | 96 |
GSM1296050 | C_lesional_day43 | 2968.77 | 93 |
GSM1296057 | D_lesional_day43 | 2264.93 | 91 |
GSM1296052 | I_lesional_day43 | 2971.09 | 93 |
GSM1296054 | J_lesional_day43 | 2627.23 | 93 |
GSM1296049 | K_lesional_day43 | 2032.96 | 89 |
GSM1296055 | W_lesional_day43 | 2177.6 | 91 |
GSM1296053 | X_lesional_day43 | 2547.45 | 92 |
GSM1296058 | Z_lesional_day43 | 2371.36 | 91 |
GSM1296051 | F_lesional_day43 | 1777.01 | 87 |
GSM1296056 | O_lesional_day43 | 976.21 | 79 |
GSM1296065 | S_lesional_day43 | 1731.97 | 87 |
GSM1296061 | T_lesional_day43 | 1032.69 | 80 |
GSM1296095 | A_non-lesional_pre-dose | 3753.07 | 95 |
GSM1296120 | B_non-lesional_pre-dose | 2920.23 | 94 |
GSM1296077 | C_non-lesional_pre-dose | 3155.2 | 94 |
GSM1296093 | D_non-lesional_pre-dose | 2127.71 | 91 |
GSM1296104 | E_non-lesional_pre-dose | 3080.22 | 93 |
GSM1296079 | F_non-lesional_pre-dose | 3518.97 | 95 |
GSM1296108 | G_non-lesional_pre-dose | 4661.56 | 97 |
GSM1296110 | H_non-lesional_pre-dose | 3829.77 | 97 |
GSM1296081 | I_non-lesional_pre-dose | 4258.2 | 96 |
GSM1296091 | J_non-lesional_pre-dose | 2308.31 | 91 |
GSM1296075 | K_non-lesional_pre-dose | 3171.11 | 94 |
GSM1296112 | L_non-lesional_pre-dose | 2783.28 | 94 |
GSM1296100 | M_non-lesional_pre-dose | 1927.27 | 89 |
GSM1296087 | O_non-lesional_pre-dose | 1813.68 | 87 |
GSM1296118 | P_non-lesional_pre-dose | 2065.23 | 91 |
GSM1296114 | Q_non-lesional_pre-dose | 4917.56 | 98 |
GSM1296097 | R_non-lesional_pre-dose | 2557.82 | 92 |
GSM1296106 | S_non-lesional_pre-dose | 3034.08 | 94 |
GSM1296102 | U_non-lesional_pre-dose | 2838.96 | 94 |
GSM1296122 | V_non-lesional_pre-dose | 2384.48 | 92 |
GSM1296089 | W_non-lesional_pre-dose | 3360.68 | 95 |
GSM1296083 | X_non-lesional_pre-dose | 4146.66 | 96 |
GSM1296116 | Y_non-lesional_pre-dose | 3505.63 | 96 |
GSM1296085 | Z_non-lesional_pre-dose | 1513.95 | 85 |